Abstract
The classical view of MS as a chronic inflammatory demyelinating disease leading to the formation of focal central nervous system (CNS) white matter (WM) lesions has been recently challenged by pathological studies and by the extensive application of modern MRI-based techniques. There is now overwhelming evidence supporting the following statements:
• MS causes widespread tissue damage in the normal-appearing white matter (NAWM) of the brain and spinal cord, whose extent and severity is more strictly associated to the clinical manifestations of the disease than the extent of focal pathology. Discrete, macroscopic lesions are just the tip of the iceberg of MS pathology.
• Grey matter (GM) damage is a consistent feature of all MS phenotypes, which is progressive from the start of the relapsing-remitting phase of the disease. As is the case for WM, GM damage is also a mixture of focal lesions and diffuse pathology. High-field strength MR scanners are improving our ability to image focal GM lesions and modern MR-based techniques are enabling us to quantify in vivo the extent and severity of GM pathology, which have been shown to correlate only moderately with the amount ofWM changes. At least part of GM pathology in MS is not secondary to retrograde degeneration of fibers traversing WM lesions.
• The neurodegenerative component of the disease is not a late phenomenon and it is not completely driven by inflammatory demyelination. In fact, neurodegeneration occurs very early in the course of MS and the correlation between MRI measures of inflammation and neurodegeneration is weak in all disease phases. The interplay of inflammation and neurodegeneration is a complex and still poorly understood phenomenon. At least part of MS-related neurodegeneration is not directly driven by Wallerian degeneration.
• Functional cortical changes can be seen in virtually all MS patients and are likely to play a central role in the ability of the MS brain to respond to tissue injury and, hence, limit the functional consequences of structural damage. MS disability is not just the result of tissue destruction but rather a balance between tissue destruction, tissue repair and adaptive cortical reorganization.
All of this calls for the concept of MS as a focal, inflammatory demyelinating, WM disease to be reexamined and to start viewing MS as a diffuse CNS disease with an important neurodegenerative component. This is central for identifying novel and effective treatment strategies.
Similar content being viewed by others
References
Adalsteinsson E, Langer-Gould A, Homer RJ, et al. (2003) Gray Matter N-Acetyl Aspartate Deficits in Secondary Progressive but Not Relapsing-Remitting Multiple Sclerosis. Am J Neuroradiol 24:1941–1945
Allen IV, McKeown SR (1979) A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 41:81–91
Audoin B, Ranjeva JP, Duong MV, et al. (2004) Voxel-based analysis of MTR images: a method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis. J Magn Reson Imaging 20:765–771
Bjartmar C, Kinkel RP, Kidd G, et al. (2001) Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 57:1248–1252
Bonneville F, Moriarty DM, Li BS, et al. (2002) Whole-brain N-acetylaspartate concentration: correlation with T2-weighted lesion volume and expanded disability status scale score in cases of relapsing-remitting multiple sclerosis. Am J Neuroradiol 23:371–375
Bozzali M, Cercignani M, Sormani MP, et al. (2002) Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. Am J Neuroradiol 23:985–988
Caramia F, Pantano P, Di Legge S, et al. (2002) A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. Magn Reson Imaging 20:383–388
Castriota Scanderbeg A, Tomaiuolo F, Sabatini U, et al. (2000) Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: assessment with diffusion MR imaging. Am J Neuroradiol 21:862–868
Cercignani M, Bozzali M, Iannucci G, et al. (2001) Magnetisation transfer ratio and mean diffusivity of normalappearing white and grey matter from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 70:311–317
Cercignani M, Iannucci G, Rocca MA, et al. (2000) Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI. Neurology 54:1139–1144
Cercignani M, Inglese M, Pagani E, et al. (2001) Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. Am J Neuroradiol 22:952–958
Chard DT, Griffin CM, McLean MA, et al. (2002) Brain metabolite changes in cortical gray and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 125:2342–2352
Ciccarelli O, Werring DJ, Barker GJ, et al. (2003) A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging-evidence ofWallerian degeneration. J Neurol 250:287–292
Ciccarelli O, Werring DJ, Wheeler-Kingshott CA, et al. (2001) Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 56:926–933
Cifelli A, Arridge M, Jezzard P, et al. (2002) Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 52:650–653
Codella M, Rocca MA, Colombo B, et al. (2002) Cerebral gray matter pathology and fatigue in patients with multiple sclerosis: a preliminary study. J Neurol Sci 194:71–74
Coles AJ, Wing MG, Molyneux P, et al. (1999) Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 46:296–304
Comi G, Filippi M, Barkhof F, et al. (2001) Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 357:1576–1582
Comi G, Filippi M, Wolinsky JS, and the European/Canadian Glatiramer Acetate Study Group (2001) European/Canadian multicenter, doubleblind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis. Ann Neurol 49:290–297
Davie CA, Barker GJ,W ebb S, et al. (1995) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 118:1583–1592
De Stefano N, Matthews PM, Fu L, et al. (1998) Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 121:1469–1477
De Stefano N, Narayanan S, Francis GS, et al. (2001) Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 58:65–70
De Stefano N, Narayanan S, Francis SJ, et al. (2002) Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Arch Neurol 59:1565–1571
Dehmeshki J, Chard DT, Leary SM, et al. (2003) The normal appearing gray matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J Neurol 250:67–74
Dehmeshki J, Ruto AC, Arridge S, et al. (2001) Analysis of MTR histograms in multiple sclerosis using principal components and multiple discriminant analysis. Magn Reson Med 46:600–609
Droogan AG, Clark CA, Werring DJ, et al. (1999) Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. Magn Reson Imaging 17:653–661
Evangelou N, Esiri MM, Smith S, et al. (2000) Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 47:391–395
Fabiano AJ, Sharma J, Weinstock-Guttman B, et al. (2003) Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study. J Neuroimaging 13:307–314
Filippi M, Inglese M (2001) Overview of diffusion-weighted magnetic resonance studies in multiple sclerosis. J Neurol Sci 186:S37-S43
Filippi M, Rocca MA (2003) Disturbed function and plasticity in multiple sclerosis as gleaned from functional magnetic resonance imaging. Curr Opin Neurol 16:275–282
Filippi M, Arnold DL, Comi G (2001) Magnetic resonance spectroscopy in multiple sclerosis. Springer, Milan
Filippi M, Bozzali M, Rovaris M, et al. (2003) Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 126:433–437
Filippi M, Campi A, Dousset V, et al. (1995) A magnetisation transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45:478–482
Filippi M, Cercignani M, Inglese M, et al. (2001) Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 56:304–311
Filippi M, Grossman RI, Comi G (1999) Magnetisation transfer in multiple sclerosis. Neurology 53(Suppl 3)
Filippi M, Iannucci G, Cercignani M, et al. (2000) A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. Arch Neurol 57:1017–1021
Filippi M, Iannucci G, Tortorella C, et al. (1999) Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 52:588–594
Filippi M, Inglese M, Rovaris M, et al. (2000) Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study. Neurology 55:940–946
Filippi M, Rocca MA, Colombo B, et al. (2002) Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. NeuroImage 15:559–567
Filippi M, Rocca MA, Falini A, et al. (2002) Correlations between structural CNS damage and functional MRI changes in primary progressive MS. NeuroImage 15:537–546
Filippi M, Rocca MA, Mezzapesa DM, et al. (2004) A functional MRI study of cortical activations associated with object manipulation in patients with MS. NeuroImage 21:1147–1154
Filippi M, Rocca MA, Mezzapesa DM, et al. (2004) Simple and complex movement-associated functional MRI changes in patients at presentation with clinically isolated syndromes suggestive of MS. Human Brain Mapping 21:108–117
Filippi M, Rovaris M, Iannucci G, et al. (2000) Whole brain volume changes in patients with progressive MS treated with cladribine. Neurology 55:1714–1718
Filippi M, Rovaris M, Inglese M, et al. (2004) Reduced brain tissue loss during randomized study of interferon beta-1a in patients at presentation with syndromes suggestive of multiple sclerosis. Lancet 364:1489–1496
Filippi M, Tortorella C, Rovaris M, et al. (2000) Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 68:157–161
Fu L, Matthews PM, De Stefano N, et al. (1998) Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121:103–113
Gadea M, Martinez-Bisbal MC, Marti-Bonmati L, et al. (2004) Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis. Brain 127:89–98
Gallo A, Rovaris M, Riva R, et al. (2005) Diffusion-tensor magnetic resonance imaging detects normalappearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. Arch Neurol 62:803–808
Ge Y, Grossman RI, Babb JS, et al. (2003) Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. Am J Neuroradiol 24:1935–1940
Ge Y, Grossman RI, Udupa JK, et al. (2001) Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis. Am J Neuroradiol 22:470–475
Ge Y, Grossman RI, Udupa JK, et al. (2002) Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis. J Comput Assist Tomogr 26:62–68
Gonen O, Catalaa I, Babb JS, et al. (2000) Total brain N-acetylaspartate. A new measure of disease load in MS. Neurology 54:15–19
Gonen O, Viswanathan AK, Catalaa I, et al. (1998) Total brain N-acetylaspartate concentration in normal, age-grouped females: quantitation with non-echo proton NMR spectroscopy. Magn Reson Med 40:684–689
Griffin CM, Chard DT, Ciccarelli O, et al. (2001) Diffusion tensor imaging in early relapsing-remitting multiple sclerosis. Mult Scler 7:290–297
Hillary FG, Chiaravalloti ND, Ricker JH, et al. (2003) An investigation of working memory rehearsal in multiple sclerosis using fMRI. J Clin Exp Neuropsychol 25:965–978
Horsfield MA, Lai M, Webb SL, et al. (1996) Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance. Magn Reson Med 36:393–400
Iannucci G, Minicucci L, Rodegher M, et al. (1999) Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T1, T2 and MT histograms. J Neurol Sci 171:121–129
Iannucci G, Rovaris M, Giacomotti L, et al. (2001) Correlation of multiple sclerosis measures derived from T2-weighted, T1-weighted, magnetization transfer, and diffusion tensor MR imaging. Am J Neuroradiol 22:1462–1467
Iannucci G, Tortorella C, Rovaris M, et al. (2000) Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. Am J Neuroradiol 21:1034–1038
Inglese M, Benedetti B, Filippi M (2005) The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis. J Neurol Sci 15:15–19
Inglese M, Ge Y, Filippi M, et al. (2004) Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. NeuroImage 21:1825–1829
Inglese M, Ghezzi A, Bianchi S, et al. (2002) Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves. Arch Neurol 59:250–255
Inglese M, Li BS, Rusinek H, et al. (2003) Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis. Magn Reson Med 50:190–195
Inglese M, Mancardi GL, Pagani E, et al. (2004) Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous hematopoietic stem cell transplantation. J Neurol Neurosurg Psychiatry 75:643–644
Kalkers NF, Hintzen RQ, van Waesberghe JH, et al. (2001) Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy. J Neurol Sci 184:155–162
Kapeller P, Brex PA, Chard D, et al. (2002) Quantitative 1H-MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 8:207–210
Kapeller P, McLean MA, Griffin CM, et al. (2001) Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. J Neurol 248:131–138
Kidd D, Barkhof F, McConnell R, et al. (1999) Cortical lesions in multiple sclerosis. Brain 122:17–26
Lee M, Reddy H, Johansen-Berg H, et al. (2000) The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. Ann Neurol 47:606–613
Lee MA, Blamire AM, Pendlebury S, et al. (2000) Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis. Arch Neurol 57:65–70
Li DKB, Paty DW, the UBC MS/MRI Analysis Research Group, and the PRISMS Study Group (1998) Magnetic resonance imaging results of PRISMS trial: a randomized, doubleblind, placebo-controlled study of interferon-beta 1a in relapsing-remitting multiple sclerosis. Ann Neurol 46:197–206
Loevner LA, Grossman RI, Cohen JA, et al. (1995) Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetisation-transfer measurements. Radiology 196:511–515
Lumdsen CE (1970) The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology.Vol 9 North-Holland, Amsterdam, pp 217–309
Mainero C, Caramia F, Pozzilli C, et al. (2004) fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. NeuroImage 21:858–867
Mancardi GL, Saccardi R, Filippi M, et al. (2001) Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology 57:62–68
McDonald WI, Compston A, Edan G, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
Mezzapesa DM, Rocca MA, Falini A, et al. (2004) A preliminary diffusion tensor and magnetization transfer magnetic resonance imaging study of early-onset multiple sclerosis. Arch Neurol 61:366–368
Miller DH, Barkhof F, Frank JA, et al. (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125:1676–1695
Molyneux PD, Barker GJ, Barkhof F, et al. (2001) Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS. Neurology 57:2191–2197
Molyneux PD, Kappos L, Polman C, et al. (2000) The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. Brain 123:2256–2263
Nusbaum AO, Tang CY, Wei TC, et al. (2000) Whole-brain diffusion MR histograms differ between MS subtypes. Neurology 54:1421–1426
Oreja-Guevara C, Rovaris M, Iannucci G, et al. (2005) Progressive gray matter damage in patients with relapsing remitting MS: a longitudinal diffusion tensor MRI study. Arch Neurol 62:578–584
Pagani E, Filippi M, Rocca MA, Horsfield MA (2005) A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis. NeuroImage 26:258–265
Pantano P, Iannetti GD, Caramia F, et al. (2002) Cortical motor reorganization after a single clinical attack of multiple sclerosis Brain 125:1607–1615
Pantano P, Mainero C, Iannetti GD, et al. (2002) Contribution of corticospinal tract damage to cortical motor reorganization after a single clinical attack of multiple sclerosis. NeuroImage 17:1837–1843
Paolillo A, Coles AJ, Molyneux PD, et al. (1999) Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath-1H. Neurology 53:751–757
Parry AM, Scott RB, Palace J, et al. (2003) Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine. Brain 126:2750–2760
Peterson JW, Bo L, Mork S, et al. (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389–400
Reddy H, Narayanan S, Arnoutelis R, et al. (2000) Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. Brain 123:2314–2320
Reddy H, Narayanan S, Matthews PM, et al. (2000) Relating axonal injury to functional recovery in MS. Neurology 54:236–239
Reddy H, Narayanan S, Woolrich M, et al. (2002) Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability. Brain 125:2646–2657
Rice GPA, for the Cladribine Clinical Study Group, Filippi M, Comi G, for the Cladribine MRI Study Group (2000) Cladribine and progressive MS. Clinical and MRI outcomes of a multicenter controlled trial. Neurology 54:1145–1155
Rocca MA, Cercignani M, Iannucci G, et al. (2000) Weekly diffusion-weighted imaging of normal-appearing white matter in MS. Neurology 55:882–884
Rocca MA, Falini A, Colombo B, et al. (2002) Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Ann Neurol 51:330–339
Rocca MA, Gallo A, Colombo B, et al. (2004) Pyramidal tract lesions and movement-associated cortical recruitment in patients with MS. NeuroImage 23:141–147
Rocca MA, Gavazzi C, Mezzapesa DM, et al. (2003) A functional MRI study of patients with secondary progressive multiple sclerosis. NeuroImage 19:1770–1777
Rocca MA, Matthews PM, Caputo D, et al. (2002) Evidence for widespread movement-associated functional MRI changes in patients with PPMS. Neurology 58:866–872
Rocca MA, Mezzapesa DM, Falini A, et al. (2003) Evidence for axonal pathology and adaptive cortical reorganisation in patients at presentation with clinically isolated syndromes suggestive of MS. NeuroImage 18:847–855
Rocca MA, Mezzapesa DM, Ghezzi A, et al. (2003) Cord damage elicits brain functional reorganization after a single episode of myelitis. Neurology 61:1078–1085
Rocca MA, Mezzapesa DM, Ghezzi A, et al. (2005) A widespread pattern of cortical activations in patients at presentation with CIS is associated with evolution to definite MS. Am J Neuroradiol 26:1136–1139
Rocca MA, Pagani E, Ghezzi A, et al. (2003) Functional cortical changes in patients with multiple sclerosis and nonspecific findings on conventional magnetic resonance imaging scans of the brain. NeuroImage 19:826–836
Rombouts SA, Lazeron RH, Scheltens P, et al. (1998) Visual activation patterns in patients with optic neuritis: an fMRI pilot study. Neurology 50:1896–1899
Rovaris M, Agosta F, Sormani MP, et al. (2003) Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Brain 126:2323–2332
Rovaris M, Bozzali M, Iannucci G, et al. (2002) Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis. Arch Neurol 59:1406–1412
Rovaris M, Bozzali M, Santuccio G, et al. (2001) In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 124:2540–2549
Rovaris M, Comi G, Rocca MA, et al. (2001) Short-term brain volume change in relapsing-remitting multiple sclerosis. Effect of glatiramer acetate and implications. Brain 124:1803–1812
Rovaris M, Filippi M (1999) Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis. Curr Opin Neurol 12:337–344
Rovaris M, Filippi M, Falautano M, et al. (1998) Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 50:1601–1608
Rovaris M, Filippi M, Minicucci L, et al. (2000) Cortical/subcortical disease burden and cognitive impairment in multiple sclerosis. Am J Neuroradiol 21:402–408
Rovaris M, Gallo A, Falini A, et al. (2005) Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis. Arch Neurol 62:898–902
Rovaris M, Gallo A, Valsasina P, et al. (2005) Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI. NeuroImage 15:1139–1146
Rovaris M, Iannucci G, Falautano M, et al. (2002) Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. J Neurol Sci 195:103–109
Santos AC, Narayanan S, De Stefano N, et al. (2002) Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. J Neurol 249:662–668
Sarchielli P, Presciutti O, Pelliccioli GP, et al. (1999) Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. Brain 122:513–521
Sarchielli P, Presciutti O, Tarducci R, et al. (2002) Localized [1] H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis. J Neurol 249:902–910
Schmierer K, Altmann DR, Kassim N, et al. (2004) Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study. Mult Scler 10:182–187
Sharma R, Narayana PA, Wolinsky JS (2001) Gray matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging. Mult Scler 7:221–226
Staffen W, Mair A, Zauner H, et al. (2002) Cognitive function and fMRI in patients with multiple sclerosis: evidence for compensatory cortical activation during an attention task. Brain 156:1275–1282
Suhy J, Rooney WD, Goodkin DE, et al. (2000) 1H-MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS. Mult Scler 6:148–155
Tartaglia MC, Narayanan S, Francis SJ, et al. (2004) The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol 61:201–207
Tortorella C, Viti B, Bozzali M, et al. (2000) A magnetization transfer histogram study of normal-appearing brain tissue in MS. Neurology 54:186–193
Traboulsee A, Dehmeshki J, Brex PA, et al. (2002) Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS. Neurology 59:126–128
Traboulsee A, Dehmeshki J, Peters KR, et al. (2003) Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities. Mult Scler 9:566–573
Trapp BD, Peterson J, Ransohoff RM, et al. (1998) Axonal transaction in the lesions of multiple sclerosis. N Engl J Med 338:278–285
Valsasina P, Rocca MA, Agosta F, et al. (2005) Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients. NeuroImage 26:822–828
van Buchem MA, Grossman RI, Armstrong C et al. (1998) Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 50:1609–1617
Werring DJ, Brassat D, Droogan AG, et al. (2000) The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis. A serial diffusion MRI study. Brain 123:1667–1676
Werring DJ, Bullmore ET, Toosy AT, et al. (2000) Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 68:441–449
Werring DJ, Clark CA, Barker GJ, et al. (1999) Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 52:1626–1632
Wilson M, Tench CR, Morgan PS, et al. (2003) Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability. J Neurol Neurosurg Psychiatry 74:203–207
Wylezinska M, Cifelli A, Jezzard P, et al. (2003) Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology 60:1949–1954
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Filippi, M., Rocca, M.A. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 252 (Suppl 5), v16–v24 (2005). https://doi.org/10.1007/s00415-005-5004-5
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-5004-5